Screening
Screening has been studied in 55 papers since 2012: 2 trials and 8 observational studies in people, 38 reviews; 25 in the past year. The newest paper, Nov 18, 2026: “Effect of public health interventions on alcohol-associated cancer risk awareness and burden: A systematic scoping review”.
55 papers study it24 findingsUpdated
Research on it is growing 32% faster than aging research as a whole: 439 papers in the latest year counted
3 new papers in 30 daysSee all 55 papers on screening
At a glance
A human study links breast cancer screening with lower mortality in women. Reviews describe mortality benefits, but a review reports no clear mortality or stroke effect in adults aged 65 or older, and another reports increased falls in frail older people. One group reports the human results; a paper declares company ties.
24 findings in 17 papers from 2016 to 2026, 5 of them since April 2026
The findings reach people, from one lab or study. 9 independent labs in 6 countries.
“After adjustment, screen detection was independently associated with 43% lower mortality (hazard ratio = 0.57, P = .003).”
1 of its findings points the other way.
- 9 independent labs in 6 countries
- 1 finding against
- Funders: National Institute for Health Research and others
- 1 of 13 findings with company ties
- Human trial2
- Humans8
- In silico6
What did studies of screening find?
13Studies of screening measured 13 outcomes; the most studied are mortality (3 studies), lifespan (2) and stroke (2).
Mortality
downin humans2no changein humans1HR 0.57
3 studies
Mortality
downin humans2no changein humans1HR 0.57
Screening is linked with lower mortality in humans (breast cancer) (43% lower mortality, HR 0.57, P = .003).
“After adjustment, screen detection was independently associated with 43% lower mortality (hazard ratio = 0.57, P = .003).”
Humansbreast cancerfemales
Journal of the American College of Radiology : JACR
Screening decreases mortality in humans.
“Screening and early detection remain essential strategies to reduce the CRC incidence and mortality”
Review
Epidemiology of colonic adenoma and cancer
Clinical endoscopy
Screening showed no clear effect on mortality in humans (adults >=65 years) (RR 0.97, 95% CI 0.93-1.01).
“There was no significant difference between any AF screening versus no screening in all-cause mortality (RR 0.97; 95%CI 0.93-1.01)”
Reviewadults >=65 years12 monthsn = 85,209
Screening for atrial fibrillation in the elderly: A network meta-analysis of randomized trials
European journal of internal medicine
Lifespan
upin humans1upin silico1
2 studies
Lifespan
upin humans1upin silico1
Screening extends lifespan in diabetic individuals.
“Early detection in diabetic individuals through targeted biomarker screening followed by timely therapeutic intervention may significantly reduce mortality, improve survival rates, and extend patient longevity.”
Reviewin diabetic individuals
Diabetology & metabolic syndrome
Screening extends lifespan in silico.
“prolonged life expectancy”
In silico
Cost-effectiveness of a risk-based secondary screening programme of type 2 diabetes
Diabetes/metabolism research and reviews
Stroke
no changein humans1downin silico1RR 0.92
2 studies
Stroke
no changein humans1downin silico1RR 0.92
Screening showed no clear effect on stroke in humans (adults >=65 years) (RR 0.92, 95% CI 0.84-1.01).
“acute cerebrovascular accident (CVA) (RR 0.92; 95%CI 0.84-1.01)”
Reviewadults >=65 years12 monthsn = 85,209
Screening for atrial fibrillation in the elderly: A network meta-analysis of randomized trials
European journal of internal medicine
Screening prevents stroke in silico (visiting the GPs office) (highest impact).
“opportunistic screening of all patients ≥65 years visiting the GPs office had the highest impact on strokes prevented.”
In silicovisiting the GPs officeopportunistic screening
European heart journal. Quality of care & clinical outcomes
Prognosis
upin humans1
1 study
Prognosis
upin humans1
Screening improves prognosis in humans (asymptomatic patients in primary care).
“screening fully contributes to improving patient prognosis.”
Reviewasymptomatic patients in primary care
Screening for adults: what's new since 2017
Revue medicale suisse
Diagnostic accuracy
upin humans1
1 study
Diagnostic accuracy
upin humans1
Screening improves diagnostic accuracy in humans (for chronic diseases in high-risk populations) (AUC 0.90 (95% CI: 0.87 - 0.93)).
“AUC was 0.90 (95% CI: 0.87 - 0.93; n = 9 studies, 8,950 participants).”
Reviewfor chronic diseases in high-risk populationsn = 8,950
Jundishapur Journal of Chronic Disease Care
Cost-effectiveness
upin humans1
1 study
Cost-effectiveness
upin humans1
Screening improves cost-effectiveness in humans (women smokers) ($24 000 per quality adjusted life year).
“screening women smokers yielded the most favourable incremental cost effectiveness ratio ($24 000 per quality adjusted life year)”
Reviewwomen smokers
European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery
Cervical cancer
downin humans1
1 study
Cervical cancer
downin humans1
Screening prevents cervical cancer in humans.
“the disease can be prevented by screening”
Review
Human Papillomavirus Screening: Design and Targeting of Human Papillomavirus Genotypes
Current topics in microbiology and immunology
Adverse health outcomes
no changein humans1HR 0.94
1 study
Adverse health outcomes
no changein humans1HR 0.94
Screening was not clearly linked with adverse health outcomes in humans (screening-detected vs existing CKD) (HR 0.94, 95% CI = 0.67 to 1.33).
“There was no difference in the composite outcome between those with existing CKD and those identified through screening (HR 0.94, 95% CI = 0.67 to 1.33).”
Humansscreening-detected vs existing CKDmedian follow-up of 3-5 yearsn = 892
BJGP open
Anticoagulants
upin humans1RR 3.26
1 study
Anticoagulants
upin humans1RR 3.26
Screening increases anticoagulants in humans (adults >=65 years) (RR 3.26, 95% CI 1.15-9.23).
“initiation of oral anticoagulation (RR 3.26; 95%CI 1.15-9.23), compared with no screening”
Reviewadults >=65 years12 monthsn = 85,209
Screening for atrial fibrillation in the elderly: A network meta-analysis of randomized trials
European journal of internal medicine
Atrial fibrillation
upin humans1RR 2.1
1 study
Atrial fibrillation
upin humans1RR 2.1
Screening increases atrial fibrillation in humans (adults >=65 years) (1.8% vs. 1.3%, RR 2.10, 95% CI 1.20-3.65).
“any AF screening (either systematic or opportunistic) was associated with higher AF detection (1.8% vs. 1.3%; risk ratio [RR] 2.10; 95% confidence interval [CI] 1.20-3.65)”
Reviewadults >=65 years12 monthsn = 85,209
Screening for atrial fibrillation in the elderly: A network meta-analysis of randomized trials
European journal of internal medicine
All 13Fewer
What is screening linked with?
7Studies link screening with 7 measures, among them mortality, Helicobacter pylori infection and hypertension.
Mortality
downin humans1
1 study
Mortality
downin humans1
Screening lowers the risk of mortality in humans (screening test).
“The aim of screening is to help detect premalignant or early-stage malignant lesions to reduce mortality.”
Reviewscreening test
Screening for Common Gynecologic Malignancies
Radiographics : a review publication of the Radiological Society of North America, Inc
Helicobacter pylori infection
upin humans1
1 study
Helicobacter pylori infection
upin humans1
Screening is associated with Helicobacter pylori infection in humans (18.0% (58/323)).
“Among 323 participants screened, 58 (18.0%) had active H. pylori infection”
Humans6 monthsn = 323
Health promotion practice
Hypertension
upin humans1+21%
1 study
Hypertension
upin humans1+21%
Screening is associated with hypertension in humans (community screening in Amman, Jordan) (20.6%).
“Our community screening revealed a high prevalence of undiagnosed hypertension (20.6%)”
Humanscommunity screening in Amman, Jordann = 932
PloS one
Urine albumin-to-creatinine ratio
upin humans1+4%
1 study
Urine albumin-to-creatinine ratio
upin humans1+4%
Screening is associated with urine albumin-to-creatinine ratio in humans (4%).
“4% with elevated UACR”
Humans
AHA Scientific Sessions 2025 abstract
Lipoprotein
upin humans1+19%
1 study
Lipoprotein
upin humans1+19%
Screening is associated with lipoprotein in humans (19%).
“19% of patients were identified with elevated Lp(a)”
Humans
AHA Scientific Sessions 2025 abstract
Falls risk
upin humans1RR 1.31
1 study
Falls risk
upin humans1RR 1.31
Screening raises the risk of falls risk in humans (frail elderly persons) (RR, 1.31 [95% CI, 1.13-1.50]).
“One RCT (n = 616) found screening of frail elderly persons associated with no difference in vision outcomes vs no screening but with significantly greater falls risk (relative risk [RR], 1.31 [95% CI, 1.13-1.50]).”
Reviewfrail elderly personsn = 616
JAMA
Glaucoma
upin humans1
1 study
Glaucoma
upin humans1
Screening is associated with glaucoma in humans (family members of people with existing glaucoma).
“regularly screening family members of people with existing glaucoma is an efficient way of detecting early glaucoma”
Reviewfamily members of people with existing glaucoma
Maturitas
Funding
1 grant since 2026National Institute on Aging$1.8M
How this record changed
Summary rewritten as its findings changed.
As it read before
A human study links screening with lower breast cancer mortality in women; another associates it with Helicobacter pylori infection. Reviews describe lower mortality and improved prognosis. Work spans 2 independent labs in 1 country; named funding includes the Korean American Community Foundation and National Institute on Aging grants.
Summary written from the findings.